Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study).

MLA

Epstein RS, et al. “Warfarin Genotyping Reduces Hospitalization Rates Results from the MM-WES (Medco-Mayo Warfarin Effectiveness Study).” Journal of the American College of Cardiology (JACC), vol. 55, no. 25, June 2010, pp. 2804–12. EBSCOhost, https://doi.org/10.1016/j.jacc.2010.03.009.

APA

Epstein RS, Moyer TP, Aubert RE, O Kane DJ, Xia F, Verbrugge RR, Gage BF, Teagarden JR, Epstein, R. S., Moyer, T. P., Aubert, R. E., O Kane, D. J., Xia, F., Verbrugge, R. R., Gage, B. F., & Teagarden, J. R. (2010). Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study). Journal of the American College of Cardiology (JACC), 55(25), 2804–2812. https://doi.org/10.1016/j.jacc.2010.03.009

Chicago

Epstein RS, Moyer TP, Aubert RE, O Kane DJ, Xia F, Verbrugge RR, Gage BF, et al. 2010. “Warfarin Genotyping Reduces Hospitalization Rates Results from the MM-WES (Medco-Mayo Warfarin Effectiveness Study).” Journal of the American College of Cardiology (JACC) 55 (25): 2804–12. doi:10.1016/j.jacc.2010.03.009.